AKR1B1 and cancer: AKR1B1 has been reported overexpressed in cancer and is associated with inflammatory mediators including nuclear factor kappa-light-chain enhancer of activated B cells (NFκB), as well as cell cycle mediators such as cyclin-dependent kinases (CDKs), and survival proteins [17].